Chan, KB; Chong, YK; Nazar, M. The identification of N,N-dimethylamphetamine (DMA) in an exhibit in Malaysia. Microgram J., 1 Jul 2003, 1 (3–4), 163–168. 247 kB. LC,MS,IR
Nakanishi, K; Miki, A; Zaitsu, K; Kamata, H; Shima, N; Kamata, T; Katagi, M; Tatsuno, M; Tsuchihashi, H; Suzuki, K. Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement. Forensic Sci. Int., 10 Apr 2012, 217 (1–3), 174–181. 397 kB. https://doi.org/10.1016/j.forsciint.2011.11.003
Krawczeniuk, AS. Identification of phenethylamines and methylenedioxyamphetamines using liquid chromatography atmospheric pressure electrospray ionization mass spectrometry. Microgram J., 1 Jan 2005, 3 (1–2), 78–100. 979 kB. MS
Stojanovska, N; Fu, S; Tahtouh, M; Kelly, T; Beavis, A; Kirkbride, KP. A review of impurity profiling and synthetic route of manufacture of methylamphetamine, 3,4-methylenedioxymethylamphetamine, amphetamine, dimethylamphetamine and p-methoxyamphetamine. Forensic Sci. Int., 10 Jan 2013, 224 (1–3), 8–26. 813 kB. https://doi.org/10.1016/j.forsciint.2012.10.040
Musshoff, F. Illegal or legitimate use? Precursor compounds to amphetamine and methamphetamine. Drug Metab. Rev., 2 Jan 2017, 32 (1), 15–44. 376 kB. https://doi.org/10.1081/DMR-100100562
Glennon, RA. Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention. Adv. Pharmacol., 1 Jan 2014, 69, 581–620. 564 kB. https://doi.org/10.1016/B978-0-12-420118-7.00015-9
Ogino, M; Naiki, T; Orui, H; Kosone, K; Yamazaki, M. Study of method for identifying phenethylamine drugs. JCCL, 11 Feb 2011, 50, 63-82. 627 kB. Japanese, English abstract
EMCDDA. New drugs in Europe, 2011, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Apr 2012. 401 kB.
Pawar, RS; Grundel, E. Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs). Drug Test. Anal., 1 Mar 2017, 9 (3), 500-517. 601 kB. https://doi.org/10.1002/dta.1980
Calderon, SN; Klein, M. A regulatory perspective on the abuse potential evaluation of novel stimulant drugs in the United States. Neuropharmacology, 1 Dec 2014, 87, 97-103. 266 kB. https://doi.org/10.1016/j.neuropharm.2014.04.001
King, LA. New phenethylamines in Europe. Drug Test. Anal., 1 Jul 2014, 6 (7-8), 808-818. 472 kB. https://doi.org/10.1002/dta.1570
Nichols, DE. Medicinal chemistry and structure-activity relationships. In Amphetamine and its Analogs; Cho, AK; Segal, DS, Eds., Academic Press, San Diego, CA, 1 Jan 1994; pp 3–41. 8.1 MB.
Biel, JH; Bopp, BA. Amphetamines: Structure-activity relationships. In Handbook of Psychopharmacology: Stimulants; Iversen, LL; Iversen, SD; Snyder, SH, Eds., Plenum Press, New York, 1 Jan 1978; pp 1–39. 1.0 MB. https://doi.org/10.1007/978-1-4757-0510-2_1
Clancy, L; Philp, M; Shimmon, R; Fu, S. Development and validation of a color spot test method for the presumptive detection of 25-NBOMe compounds. Drug Test. Anal., 19 Aug 2020, 13 (5), 929-943. 11.3 MB. https://doi.org/10.1002/dta.2905 #N,N-dimethylamphetamine
Escamilla, B; Bertsch, A. N,N-Dimethylamphetamine in Sacramento. JCLIC, 1 Oct 2004, 14 (4), 19-22. 139 kB. MS
Cohen, WS. Ephedra used as a precursor in methamphetamine manufacturing. JCLIC, 1 Apr 2006, 16 (2), 21–22. 81 kB. MS
Chappell, JS. Infrared absorption properties of solid-dosage drug substances. Part II. Infrared absorption by hydrogen bonds. JCLIC, 1 Mar 2014, 24 (2-3), 9-27. 1.6 MB. IR
King, LA. Designer drugs related to amphetamine (1990–1996). JCLIC, 1 Jul 1996, 6 (3), 15-16. 562 kB. #3
Sekine, H; Nakahara, Y. Abuse of smoking methamphetamine mixed with tobacco: II. The formation mechanism of pyrolysis products. J. Forensic Sci., 1 May 1990, 35 (3), 580–590. 436 kB. https://doi.org/10.1520/JFS12864J #Dimethylamphetamine MS,NMR,IR,other
Kram, TC; Kruegel, AV. The identification of impurities in illicit methamphetamine exhibits by gas chromatography/mass spectrometry and nuclear magnetic resonance spectroscopy. J. Forensic Sci., 1 Jan 1977, 22 (1), 40–52. 444 kB. https://doi.org/10.1520/JFS10366J #VII GC,MS,NMR
Philp, M; Shimmon, R; Stojanovska, N; Tahtouh, M; Fu, S. Development and validation of a presumptive colour spot test method for the detection of piperazine analogues in seized illicit materials. Anal. Methods, 1 Jan 2013, 5 (20), 5402. 783 kB. https://doi.org/10.1039/c3ay40511g #Dimethamphetamine (DMA) MS,NMR,IR,spot